Zerumbone combined with gefitinib alleviates lung cancer cell growth through the AKT/STAT3/SLC7A11 axis.
Sign Up to like & getrecommendations! Published in 2023 at "Neoplasma"
DOI: 10.4149/neo_2022_220418n423
Abstract: Zerumbone had been verified as a potential anti-cancer agent. Our research aimed to investigate the effect of zerumbone combined with gefitinib in lung cancer. Human pulmonary alveolar epithelial cells (HPAEpiC), A549, and H460 cell lines… read more here.
Keywords: zerumbone combined; lung cancer; cell; gefitinib ... See more keywords